Thomas D Talcott

Title: Thomas D Talcott: Innovator in Eye Treatment Technologies

Introduction

Thomas D Talcott is a notable inventor based in Irvine, CA, who has made significant contributions to the field of ophthalmology. He holds a total of 3 patents that focus on innovative methods and compositions for treating defects in the eye. His work has the potential to enhance the quality of life for individuals with vision impairments.

Latest Patents

One of Talcott's latest patents is titled "Correction of defects in the eye and compositions therefor." This patent describes a method of treating defective lenses in the eye by removing the natural lens while leaving the lens capsule intact. A curable liquid composition, which includes a crosslinkable siloxane polymer, a crosslinker, and a crosslinking catalyst, is injected into the lens capsule. This composition cures at body temperature to form a solid, transparent synthetic lens that remains clear in the presence of physiological fluids. Another significant patent is for "Low oiling gel filled articles, siloxane gels and liquids therefor." This invention involves a low oiling gel filled article that comprises a polydiorganosiloxane gel contained within a polysiloxane rubber envelope. The gel is characterized as the addition product of specific prepolymers, and the patent also discloses processes for making these complex fluids.

Career Highlights

Throughout his career, Talcott has worked with several prominent companies, including Innovative Surgical Products, Inc. and Boehringer Mannheim GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Talcott has collaborated with various professionals, including George M Wright, to further advance his research and inventions. Their combined expertise has contributed to the development of groundbreaking technologies in eye treatment.

Conclusion

Thomas D Talcott is a distinguished inventor whose work in eye treatment technologies has the potential to revolutionize the way vision defects are addressed. His innovative patents and collaborations highlight his commitment to improving healthcare solutions.